Vitamin K2 is the new cardio-support nutrient because clinical studies have confirmed it delivers what no other compound can: reduction in arterial stiffening.
But not all K2s have been shown to deliver this health benefit.
MenaQ7® was the Vitamin K2 as MK-7 used in 19+ published clinical trials confirming safety & efficacy, including the ground-breaking studies demonstrating K2 is a cardio-support nutrient. This evidence is why MenaQ7® is the only K2 as MK-7 patented for cardiovascular health.
Visit NattoPharma at SSE Booth C129 to discuss proven MenaQ7® and its robust patent portfolio.